Bristol-Myers Squibb sell Morgan Stanley
Start price
19.07.23
/
50%
€55.70
Target price
19.07.24
€52.70
Performance (%)
-23.67%
Price
03.05.24
€40.88
Summary
This prediction is currently active. The prediction for Bristol-Myers Squibb shows a convincing performance of -23.67%. Dividends of €1.64 are taken into consideration when calculating the performance. This prediction currently runs until 19.07.24. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Bristol-Myers Squibb | -2.493% | -2.493% |
iShares Core DAX® | -0.922% | -1.078% |
iShares Nasdaq 100 | 0.371% | -0.556% |
iShares Nikkei 225® | 2.224% | -2.825% |
iShares S&P 500 | -0.026% | -0.788% |
Comments by Morgan_Stanley for this prediction
In the thread Bristol-Myers Squibb diskutieren
Bristol-Myers Squibb (NYSE: BMY) had its "underweight" rating re-affirmed by analysts at Morgan Stanley. They now have a $59.00 price target on the stock.
Ratings data for BMY provided by MarketBeat
Stopped prediction by Morgan_Stanley for Bristol-Myers Squibb
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€49.80
27.10.23
27.10.23
€47.31
27.10.24
27.10.24
-15.71%
03.05.24
03.05.24
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€53.40
11.10.23
11.10.23
€52.70
11.10.24
11.10.24
-21.39%
03.05.24
03.05.24